Details for Patent: 9,566,270

Title:	Methods for treating irritable bowel syndrome (IBS)
Abstract:	The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.
Inventor(s):	Forbes; William (Raleigh, NC), Bortey; Enoch (Chapel Hill, NC)
Assignee:	Salix Pharmaceuticals, Ltd (Bridgewater, NJ)
Filing Date:	Jan 31, 2013
Application Number:	13/755,578
Claims:	1. A method of treating bloating associated with alternating IBS in a subject 65 years old or older, said method comprising administering, for between 14 days and 24 months, 550 mg of rifaximin TID, to the subject, thereby treating bloating associated with alternating IBS in the subject 65 years old or older. 2. The method of claim 1, wherein the treating of bloating comprises a reduction of bloating. 3. The method of claim 2, wherein the reduction of bloating is achieved following 7 days of the administration of the rifaximin. 4. The method of claim 2, wherein the reduction of bloating comprises an affirmative response from a subject if asked whether they have had a reduction in bloating. 5. The method of claim 1, further comprising treating one or more symptoms associated with alternating IBS selected from cramping, pain, diarrhea, constipation, lumpy stool, watery stool, frequent stool production, abdominal pain, abdominal discomfort, urgency, and tenesmus. 6. The method of claim 2, wherein the reduction in bloating is a reduction as compared with baseline. 7. The method of claim 6, wherein baseline is established prior to treatment. 8. The method of claim 7, wherein the reduction in bloating is achieved following 7 days of the administration of the rifaximin. 9. The method of claim 8, wherein the reduction in bloating comprises an affirmative response from a subject if asked whether they have had a reduction in bloating. 10. The method of claim 1, wherein the rifaximin is administered for 14 days.